Select Publications
Journal articles
2024, 'A paradigm shift in how we treat pediatric low-grade glioma—Targeting the molecular drivers', Neuro-Oncology, 26, pp. 593 - 595, http://dx.doi.org/10.1093/neuonc/noae008
,2023, 'DDDR-30. IDENTIFICATION OF DRIVERS OF RESISTANCE IN BRAFV600E PEDIATRIC HIGH-GRADE GLIOMA AND NOVEL THERAPEUTIC TARGETS', Neuro-Oncology, 25, pp. v112 - v112, http://dx.doi.org/10.1093/neuonc/noad179.0423
,2022, 'Resistance mechanisms in BRAFV600E paediatric high-grade glioma and current therapeutic approaches', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.1031378
,2021, 'Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells', Molecular Genetics and Metabolism Reports, 29, http://dx.doi.org/10.1016/j.ymgmr.2021.100811
,2021, 'Therapeutic targets in diffuse midline gliomas—an emerging landscape', Cancers, 13, http://dx.doi.org/10.3390/cancers13246251
,2021, 'Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG', Cell Reports, 35, pp. 108994, http://dx.doi.org/10.1016/j.celrep.2021.108994
,2017, 'Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet', JOURNAL OF NEUROCHEMISTRY, 141, pp. 287 - 295, http://dx.doi.org/10.1111/jnc.13976
,2016, 'Selective normalisation of regional brain bis(monoacylglycero)phosphate in the mucopolysaccharidosis 1 (Hurler) mouse', EXPERIMENTAL NEUROLOGY, 277, pp. 68 - 75, http://dx.doi.org/10.1016/j.expneurol.2015.12.012
,